Margarita Chavez, Managing Director of the Chicago-based office at AbbVie Ventures. See sector focus and contact routes.
Margarita Chavez, Managing Director of the Chicago-based office at AbbVie Ventures, leads investments in early-stage biotechs (primarily Seed and Series A) with check sizes ranging from $3 million to $30 million. Her portfolio includes notable companies such as Carisma Therapeutics (CAR-M cancer technology), Alector, Morphic Therapeutics, and Enthera, focusing on oncology, immunology, neuroscience, eye care, and aesthetics. Chavez’s distinctive thesis centers on backing novel, transformational therapeutics at discovery and pre-clinical stages that address critical unmet medical needs while leveraging AbbVie’s internal drug development expertise.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in North Chicago.
Investors like Margarita Chavez · Full investor directory · Investor access · Company funding database